Keytruda
Recently, concerns have emerged in India over a black market for Keytruda, driven by high costs and limited access.
- Keytruda is the brand name of pembrolizumab, an advanced cancer immunotherapy drug.
- Developed by Merck & Co., it is among the world’s top-selling cancer drugs.
- It belongs to a class called checkpoint inhibitors, which enhance immune response against cancer.
- Works by blocking PD-1 receptors on T-cells, preventing cancer cells from evading immune detection.
- Enables the body’s immune system to identify and destroy cancer cells more effectively.
- Used to treat cancers like lung, melanoma, cervical, kidney, and certain breast cancers.
- Unlike chemotherapy, ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 India Advances Defence Capabilities with Key Procurement Agreements
- 2 Indian Navy Commissions INS Taragiri Stealth Frigate
- 3 Digital Humans
- 4 India Lays Foundation for First Advanced 3D Chip Packaging Unit in Odisha
- 5 IVRI Produces Indigenous Sahiwal Calves Using IVF Technology
- 6 India Demonstrates 1,000-km Quantum Communication Network
- 7 India’s Prototype Fast Breeder Reactor (PFBR) Achieves Criticality
- 8 Indian Navy Inducts ‘Dunagiri’ Stealth Frigate
- 9 Indian Navy Inducts ‘Sanshodhak’
- 10 ‘Malwan’ Anti-Submarine Warfare Shallow Water Craft
